title: Expression of AP-2α, AP-2γ and ESDN in primary melanomas: correlation with histopathological features and potential prognostic value.
authors.forename: Simona
authors.initials: S
authors.lastname: Osella-Abate
authors.forename: Mauro
authors.initials: M
authors.lastname: Novelli
authors.forename: Pietro
authors.initials: P
authors.lastname: Quaglino
authors.forename: Francesca
authors.initials: F
authors.lastname: Orso
authors.forename: Benedetta
authors.initials: B
authors.lastname: Ubezio
authors.forename: Carlo
authors.initials: C
authors.lastname: Tomasini
authors.forename: Ester
authors.initials: E
authors.lastname: Berardengo
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Bernengo
authors.forename: Daniela
authors.initials: D
authors.lastname: Taverna
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D008545:Melanoma / Q000378:metabolism* / Q000473:pathology*; D008565:Membrane Proteins / Q000378:metabolism*; D009361:Neoplasm Invasiveness; D011379:Prognosis; D012878:Skin Neoplasms / Q000378:metabolism* / Q000473:pathology*; D050656:Transcription Factor AP-2 / Q000378:metabolism*
chemical_list: D014408:Biomarkers, Tumor; C436326:DCBLD2 protein, human; D008565:Membrane Proteins; D050656:Transcription Factor AP-2